dolutegravir Supplier - Clearsynth Canada INC

dolutegravir

Description :

Dolutegravir is a second generation HIV-1 integrase strand transfer inhibitor. Dolutegravir is currently in Phase III clinical trials for the treatment of HIV infection.

Seller Info :

Clearsynth Canada INC

Product Details :

Cas Number1051375-16-6

Categories :

Research Chemicals
About Suppliers :
Clearsynth Canada INC

Clearsynth is a technology based, research driven enterprise with the World's Largest Inventory of Reference Standards & Research Chemicals. Clearsynth aim to enable the research community in accelerated Read More..

www.worldofchemicals.com uses cookies to ensure that we give you the best experience on our website. By using this site, you agree to our Privacy Policy and our Terms of Use. X